generics

Roche comes up short in its attempt to hold off generic competition to Esbriet
Endpoints
Thu, 03/24/22 - 08:38 pm
Roche
Esbriet
IPF
generics
Novartis' Sandoz, following Pfizer's lead, launches 2nd carcinogen-related drug recall this week
Fierce Pharma
Wed, 03/23/22 - 10:58 pm
Novartis
Sandoz
product recalls
generics
Novo Nordisk and Novartis put Victoza patent suit to bed, teeing up Sandoz copycat by 2024
Fierce Pharma
Wed, 03/23/22 - 10:38 am
Novo Nordisk
Novartis
Sandoz
Victoza
generics
patents
diabetes
FDA clears first generic of AZ’s blockbuster Symbicort
Pharmaforum
Wed, 03/16/22 - 10:21 am
Viatris
AstraZeneca
generics
FDA
Symbicort
Sandoz bulks up ahead of possible sale with Coalesce buy
Pharmaforum
Mon, 03/14/22 - 10:21 am
Novartis
Sandoz
generics
M&A
Coalesce Product Development
Bristol Myers Squibb's Revlimid finally faces competition in the U.S. with Teva's generic launch
Fierce Pharma
Mon, 03/7/22 - 10:51 pm
Bristol Myers Squibb
Revlimid
Multiple Myeloma
generics
Teva Pharmaceutical
When the $10K brand name drug is more affordable than its $450 generic: How PBMs control the system
Endpoints
Sun, 02/20/22 - 11:52 am
PBMs
drug pricing
generics
Generic drug approvals continued to fall in 2021
RAPS.org
Wed, 02/16/22 - 11:13 pm
FDA
generics
Is the battle over 'skinny' generic labels headed to the Supreme Court?
Endpoints
Wed, 02/16/22 - 11:10 pm
Teva Pharmaceutical
generics
skinny labels
Court sides with Teva over Emergent in generic Narcan suit
Endpoints
Tue, 02/15/22 - 11:36 pm
Teva Pharmaceutical
legal
Emergent BioSolutions
generics
Narcan
opioids
No news anytime soon on Sandoz sale, says Novartis
Pharmaforum
Thu, 02/3/22 - 10:35 am
Novartis
Vas Narasimhan
Sandoz
generics
M&A
AbbVie's blockbuster eye drug Restasis under threat as FDA approves Viatris' copycat
Fierce Pharma
Wed, 02/2/22 - 11:50 pm
AbbVie
earnings
Restasis
FDA
generics
AbbVie notches reprieve in antitrust case involving blood pressure med snagged in $63B Allergan megamerger
Fierce Pharma
Wed, 01/26/22 - 11:00 am
AbbVie
antitrust
Bystolic
generics
Allergan
This Week at FDA: Generic drug approvals continue downward trend, new guidance on clinical trial diversity coming
RAPS.org
Fri, 01/21/22 - 11:01 am
FDA
regulatory
clinical trials
clinical trial diversity
generics
Viatris yanks one batch of diabetes med Semglee because of missing label risks
Fierce Pharma
Fri, 01/21/22 - 11:00 am
Viatris
diabetes
Semglee
insulin
generics
27 drugmakers to provide generic COVID drug to low-income countries
Pharmaforum
Thu, 01/20/22 - 11:29 pm
generics
Merck
molnupiravir
COVID-19
antivirals
Mark Cuban's drug company launches online pharmacy
Beckers Hospital Review
Wed, 01/19/22 - 11:07 pm
Mark Cuban
generics
Mark Cuban Cost Plus Drugs
online pharmacies
‘Skinny labels’ on generics can save patients money, research shows, but recent court decisions cloud future
Endpoints
Wed, 01/12/22 - 11:28 pm
generics
skinny labels
Teva and Novartis’ Sandoz launch Narcan generics on same day, brand marketer Emergent remains in play
Endpoints
Wed, 01/5/22 - 10:47 pm
Teva Pharmaceutical
Novartis
Sandoz
generics
Narcan
Emergent BioSolutions
Dr Reddy's to launch generic COVID-19 Merck drug at about 50 cents a pill
Reuters
Tue, 01/4/22 - 10:46 pm
Dr Reddy's
Merck
generics
COVID-19
molnupiravir

Pages